论文信息 - Phase I Clinical Trial of the Anti-CD22 Immunotoxin CAT-8015 (HA22) for Pediatric Acute Lymphoblastic Leukemia (ALL). - 字舞流文

Phase I Clinical Trial of the Anti-CD22 Immunotoxin CAT-8015 (HA22) for Pediatric Acute Lymphoblastic Leukemia (ALL).

C. Pui | I. Pastan | M. Stetler-Stevenson | S. Jeha | D. Bhojwani | R. Kreitman | A. Wayne | J. McDevitt | D. FitzGerald | K. Kaucic